Stock Events

Stock Events

Denali Therapeutics (D2NL34.SA) Q3 2024 Earnings

1AugConfirmed

Q4 2023

Q2 2024

Q3 2024

-4.24

-3.96

-3.68

-3.39

Details

Expected EPS

-4.039595229000001

Actual EPS

-3.3928540000000003

Surprise EPS

0.65

Surprise Percent

+16.01%

Description

Denali Therapeutics (D2NL34.SA) has reported earnings of -3.3928540000000003 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.